WB quantification of ATF5 expression in tumor and normal brain samples by Huang et al. [31] revealed highly elevated levels in high-grade gliomas and no significant difference between normal brain and low-grade gliomas. This evidence concerns the gene ATF5 and central nervous system cancer.